Deep vein thrombosis treated with streptokinase or heparin: A randomized study

Arthur J. Seaman, Herbert H. Common, Josef Rösch, Charles T. Dotter, John M. Porter, Thomas D. Lindell, Lliam L. Lawler, William J. Schlueter

Research output: Contribution to journalArticlepeer-review

45 Scopus citations


Randomly assigned streptokinase or heparin therapy was studied in 50 patients with deep vein thrombosis of less than 2 weeks' duration. Veno graphy was performed prior to therapy, after 3 days, and after 10 days. Two radiologists who were unaware of the patient's therapy compiled a single average lytic score for each patient at each time interval. Lysis of venous thrombi was significantly greater with streptokinase than with heparin after 3 days, but not after 10 days of treatment. Lytic scores achieved with streptokinase were significantly better than those achieved with heparin therapy (P <.01) in male patients who were symptomatic for 3 days or less. In females, regardless of the duration of symptoms, throm bolytic results obtained with streptokinase were not significantly different than results obtained with heparin.

Original languageEnglish (US)
Pages (from-to)549-556
Number of pages8
Issue number10
StatePublished - Oct 1976
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Deep vein thrombosis treated with streptokinase or heparin: A randomized study'. Together they form a unique fingerprint.

Cite this